Thelium Therapeutics is a preclinical stage company developing first-in-class, non-immunosuppressive small molecule therapies to restore epithelial barrier function in inflammatory diseases. We employ novel precision targeting approaches for barrier restoration that yields disease attenuation by taming immunological activation.
Member count: 1-10
Investors 1
| Date | Name | Website |
| 09.07.2021 | MBC BioLab... | mbcbiolabs... |